TrialFind
Saved trials
Back to results
Completed
Phase 3
An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT05061719
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Clinical Site
Phoenix, Arizona, United States
+108 additional locations
View on ClinicalTrials.gov
Official details
An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — TrialFind